A 1 to 1000 SARS-CoV-2 reinfection proportion in members of a large healthcare provider in Israel: a preliminary report

Galit Perez, Tamar Banon, Sivan Gazit, Shay Ben Moshe, Joshua Wortsman, Daniel Grupel, Asaf Peretz, Amir Ben Tov, Gabriel Chodick, Miri Mizrahi-Reuveni, Tal Patalon
doi: https://doi.org/10.1101/2021.03.06.21253051

Article Information

doi 
https://doi.org/10.1101/2021.03.06.21253051
History 
  • March 8, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Galit Perez, MN MA1,*,
  2. Tamar Banon, MSc2,
  3. Sivan Gazit, MD MA1,
  4. Shay Ben Moshe, MSc3,1,
  5. Joshua Wortsman, MD1,
  6. Daniel Grupel, MD3,
  7. Asaf Peretz, MD4,
  8. Amir Ben Tov, MD2,5,
  9. Gabriel Chodick, PhD MHA2,5,
  10. Miri Mizrahi-Reuveni, MD MHA6 and
  11. Tal Patalon, MD2
  1. 1Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services, Israel
  2. 2Maccabitech Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv, Israel
  3. 3Ben-Gurion University, Beer Sheva, Israel
  4. 4Internal Medicine COVID-19 Ward, Samson Assuta Ashdod University Hospital, Ashdod Israel
  5. 5Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
  6. 6Health Division, Maccabi Healthcare Services, Tel Aviv, Israel
  1. ↵*Corresponding author:
    Galit Perez, perez_g{at}mac.org.il
Back to top
Posted March 08, 2021.
Download PDF
Data/Code
Email
A 1 to 1000 SARS-CoV-2 reinfection proportion in members of a large healthcare provider in Israel: a preliminary report
Galit Perez, Tamar Banon, Sivan Gazit, Shay Ben Moshe, Joshua Wortsman, Daniel Grupel, Asaf Peretz, Amir Ben Tov, Gabriel Chodick, Miri Mizrahi-Reuveni, Tal Patalon
medRxiv 2021.03.06.21253051; doi: https://doi.org/10.1101/2021.03.06.21253051
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area